Cargando…
Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in Europe
Chimeric antigen receptor (CAR)-T cell therapy is a new class of cellular immunotherapies that involves ex vivo genetic modification of T cells to incorporate an engineered CAR. After infusion into the patient, the CAR-expressing T cells recognize specific tumor targets and induce an immune response...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745952/ https://www.ncbi.nlm.nih.gov/pubmed/31723747 http://dx.doi.org/10.1097/HS9.0000000000000018 |